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epithelia [1]. However, inmost othermammalian cells, recep-
tor-dependent elevation of Ins(3,4,5,6)P4 levels is an ‘‘or-
phan’’ response that lacks biological significance [2]. We
set out to identify Cl2 channel(s) and/or transporter(s) that
are regulated by Ins(3,4,5,6)P4 in vivo. Several candidates
[3–5] were excluded through biophysical criteria, electro-
physiological analysis, and confocal immunofluorescence
microscopy. Then, we heterologously expressed ClC-3 in
the plasma membrane of HEK293-tsA201 cells; whole-cell
patch-clamp analysis showed Ins(3,4,5,6)P4 to inhibit Cl
2
conductance through ClC-3. Next, we heterologously ex-
pressed ClC-3 in the early endosomal compartment of BHK
cells; by fluorescence ratio imaging of endocytosed FITC-
transferrin, we recorded intra-endosomal pH, an in situ bio-
sensor for Cl2 flux across endosomal membranes [6]. A
cell-permeant, bioactivatable Ins(3,4,5,6)P4 analog elevated
endosomal pH from 6.1 to 6.6, reflecting inhibition of ClC-3.
Finally, Ins(3,4,5,6)P4 inhibited endogenous ClC-3 conduc-
tance in postsynaptic membranes of neonatal hippocampal
neurones. Among other ClC-3 functions that could be regu-
lated by Ins(3,4,5,6)P4 are tumor cell migration [7], apoptosis
[8], and inflammatory responses [9]. Ins(3,4,5,6)P4 isaubiqui-
tous cellular signal with diverse biological actions.
Results and Discussion
ITPK1 is a multifunctional kinase and phosphotransferase that
interconverts Ins(3,4,5,6)P4 with Ins(1,3,4,5,6)P5 [10]. The
poise of this substrate cycle becomes weighted in favor of
Ins(3,4,5,6)P4 accumulation whenever phospholipase C is re-
ceptor-activated [10, 11]. Intracellular [Ins(3,4,5,6)P4] rises
from 1 mM in resting cells up to 10 mM after receptor activation
[11]. In epithelial cells, elevated [Ins(3,4,5,6)P4] inhibits Ca
2+-
activated Cl2 efflux [1, 12–14]. However, no one has
*Correspondence: shears@niehs.nih.govestablished the molecular identity of any Cl2 channel (or trans-
porter) that is regulated by Ins(3,4,5,6)P4 in vivo. For several
years, the usual suspects that have been rounded up in litera-
ture reviews [3–5] have fallen into three separate families:
CLCA, bestrophin, and ClC. We exclude the CLCA family be-
cause its pharmacological properties (inhibition by dithiothrei-
tol [15]) and electrophysiological parameters (13–30 pS unitary
conductance [15]) do not match those of the Ins(3,4,5,6)P4-
inhibited Cl2 current (insensitivity to dithiothreitol and 1–2 ps
unitary conductance [12]). Another candidate-channel family
is the bestrophins. For examination of this possibility, HEK
cells were transfected with hBEST1 as previously described
[16] and whole-cell Cl2 current was recorded by patch-clamp
analysis. The intracellular solution contained 125–150 nM
[Ca2+]free and 2 mM Mg-ATP, sufficient to provide 50%–75%
of maximal channel activation [16]. Whole-cell current was
unaffected when 10 mM Ins(3,4,5,6)P4 was perfused into the
cell (Hartzell, Yu, and Shears, data not shown). Moreover, the
Cl2 currents carried by bestrophins exhibited a near-linear re-
lationship between current and voltage (data not shown, [4]), in
contrast to the outward rectification that typifies Ins(3,4,5,6)P4-
regulated Cl2 currents [12, 14].
We then turned our attention to the ClC family. These are
proteins that are often predominantly intracellular, but at least
one of them, ClC-3, is also located in the plasma membrane
[17]. HEK293-tsA201 cells (a popular cell line for ion-chan-
nel-expression studies) were transfected with ClC-3; electro-
physiological analysis of the tsAClC-3 cells revealed a strongly
outwardly rectifying Cl2 current (Figure 1A), in agreement with
previous studies of ClC-3 [18], as well as of ClC-4 and ClC-5
[19]. When CaMKII was perfused into the cell through the
patch pipette, whole-cell current increased > 10-fold within
10–20 min (Figure 1A); the delay reflects the small diffusion co-
efficient of large molecules, as well as the significant diffu-
sional barrier imposed by the pipette tip [20]. Another conse-
quence of CaMKII addition was that the relationship between
current and voltage became more linear, thereby reducing
the strength of the outward rectification (Figure 1A). CaMKII
did not affect Cl2 currents in tsA cells in which ClC-3 was
not overexpressed (data not shown, [21]). The addition of
Ins(3,4,5,6)P4 to the pipette solution prevented CaMKII
from activating the ClC-3-dependent Cl2 current (Figures 1B
and 1C). Both the potency of Ins(3,4,5,6)P4 (IC50 = 4.6 mM;
Figure 1D) and its specificity of action (neither Ins(1,3,4,5,6)P5
nor Ins(1,4,5,6)P4 affected Cl
2 current; Figures 1B and 1C)
are defining characteristics of the action of Ins(3,4,5,6)P4
upon native CaMKII-activated Cl2 current [14]. The inhibition
of native current by Ins(3,4,5,6)P4 also has the distinctive
feature of being attenuated by okadaic acid [12]. A similar
pharmacological effect was observed in tsAClC-3 cells (Fig-
ure 1E). This is the first demonstration of a physiologically rel-
evant and specific effect of Ins(3,4,5,6)P4 upon a defined Cl
2
channel in intact cells. In particular, the inhibition by
Ins(3,4,5,6)P4 of inward Cl
2 current (Figures 1B and 1C), which
by convention represents Cl2 efflux from the cell, recapitulates
previous demonstrations of physiologically relevant inhibition
by Ins(3,4,5,6)P4 of Cl
2 secretion from secretory epithelial cells
[1, 13].
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1601Next, we investigated whether Ins(3,4,5,6)P4 regulates ClC-3
in other biological contexts. In addition to being present in the
plasma membrane, ClC-3 is well documented as localizing in
the transferrin-positive endosomal compartment [17, 22–24]
along with ClC-4 and ClC-5 [25, 26]. It has been proposed that
Cl2 influx into the endosomes through ClCs provides the charge
neutralization without which the electrogenic H+-ATPase
would not be capable of acidifying the vesicle interior
[6, 24, 27]. A recent complication for the latter hypothesis is
the determination that ClC-4 and ClC-5 are actually nCl2/H+
antiporters (n > 1) [28, 29]. This development does not oblige
ClC-3 to function exclusively as a transporter rather than as
a channel [30]. Functional switching between the two modes
is also a possibility, perhaps mediated by CaMKII-dependent
phosphorylation (Figure 1) or by the association of regulatory
proteins [31]. Even in the event of nCl2/H+ antiport driven by
vesicular ClC-3, its asymmetrical stoichiometry would still pro-
vide the necessary electrogenic support for luminal acidifica-
tion [6]. Nevertheless, charge neutralization by nCl2/H+ anti-
port is clearly less energetically efficient than Cl2 influx [18].
Moreover, the outward rectification of ClCs has been argued
to favor the opposite direction for Cl2 flux; namely, out of the
endosome and into the cytoplasm [18]. This proposed Cl2
exit could then be coupled to H+ influx into the endosome,
thereby still facilitating luminal acidification [18]. The electro-
chemical driving force for this ion exchange could arise from
the high intravesicular [Cl2] that originates from the
Figure 1. Electrophysiological Analysis of the Inhibition of CaMKII-
Activated Cl2 Current by Ins(3,4,5,6)P4 in tsA
ClC-3 Cells
(A) Representative whole-cell currents from tsAClC-3 cells in which au-
tonomous CaMKII (20 mg/ml) was included in the pipette solution. Upper
left panel: Representative time-course of current elicited during depola-
rizing voltage pulses to 110 mV from a holding potential of240 mV every
10 s. Upper right panel: Families of currents recorded at the initiation
(‘‘initial’’) and peak of CaMKII-mediated current activation, during hyper-
polarizing and depolarizing voltage pulses from a holding potential
of 240 mV to potentials between 2110 and 110 mV at 10 mV intervals.
Lower panels: Average relationship between current and voltage from
seven cells.
(B–E) Analysis of whole-cell current responses to 100 mM Ins(1,3,4,5,6)P5,
100mM Ins(1,4,5,6)P4, or 10mM (unless otherwise indicated) Ins(3,4,5,6)P4.
(B) Average relationship between current and voltage for current families
elicited as in (A). (C) Mean current densities determined at 110 mV
and 2110 mV, with cell numbers indicated above each bar. (D) Effect of
Ins(3,4,5,6)P4 concentration upon CaMKII-activated current (n = 3-6).
Data are fitted to a single-site binding curve. (E) Representative time
course of current activation by CaMKII (peak current = 3.18 6 0.34 nA,
n = 7) plus (in the pipette solution) either 10 mM Ins(3,4,5,6)P4 + 100 nM
okadaic acid (‘‘OKA’’) (peak current = 2.64 6 0.68 nA, n = 3) or 10 mM
Ins(3,4,5,6)P4 alone.
In panels that contain error bars, these represent standard errors of the
mean.
extracellular fluid that is inevitably trapped inside endo-
somes during their formation at the plasma membrane. Ir-
respective of the mechanisms involved, there is no doubt
that ClCs contribute to endosomal acidification [6]. Thus,
we recorded endosomal pH as an in situ biosensor for the
regulation of ClC activity by Ins(3,4,5,6)P4.
For these experiments, we chose baby hamster kidney
(BHK) cells in which endogenous ClC-3 expression was be-
low detectable levels (Figure 2A). We generated a new BHK
cell line in which ClC-3 was stably transfected. Western-
blot analysis of the BHKClC-3 cell extracts revealed a band
of 125–130 kDa (Figure 2A), representing the fully
glycosylated mature protein. A smaller band of approximately
90 kDa may be immature ClC-3 (Figure 2A). Confocal immuno-
fluorescence analysis revealed an intracellular, punctate distri-
bution of ClC-3 (Figure 2A), indicating that it was localized in
endosomes that were largely vesicular in nature. Next, the
endocytic compartment in BHK cells was preloaded with the
pH-sensitive fluorophore FITC conjugated to transferrin.
Transferrin-positive endosomes have both tubulovesicular
and morphologically distinct, punctate (globular) elements
[32]. The latter subcompartment was the focus of our experi-
ments, because exogenously expressed endosomal ClC-3
also showed a punctate distribution (Figure 2A). Typical exam-
ples of this relatively homogeneous population of punctate
transferrin signals (103 6 3 pixels) are highlighted by yellow
arrows in Figure 2B. Luminal pH was determined in situ by
fluorescence-ratio imaging of endosomes from single cells
(Figure 2B and [25]). We employed a ratiometric analysis to
compensate for any organelle-to-organelle variation in the lu-
minal concentration of FITC-transferrin. The fluorophore signal
was calibrated by equilibration of cells with buffers of known
pH values containing ionophores so as to dissipate intracellu-
lar pH gradients (Figures 2B and 2C). The fluorescence ratio
varied linearly with pH within the range 5.7–7.3 (r = 0.992).
In intact cells, [Ins(3,4,5,6)P4] can be experimentally ele-
vated by overexpression of ITPK1, but the multifunctional
nature of this enzyme [10] causes accompanying changes in
the levels of many additional inositol phosphates [33]. Instead,
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a cell-permeant, bioactivatable analog, Bt2-Ins(3,4,5,6)P4/PM
[34]. This procedure did not affect endosomal pH in wild-
type (WT) BHK cells (Figure 2D). Thus, in these cells, endoge-
nous endosomal Cl2 channels were not substantially regu-
lated by Ins(3,4,5,6)P4. In contrast, in BHK
ClC-3 cells, treatment
with cell-permeant Ins(3,4,5,6)P4 led to significant alkalization
of endosomal pH (0.5 pH units; Figure 2D). An IC50 value of 4.5
mM was obtained (Figure 2E), similar to the potency of
Ins(3,4,5,6)P4 action upon ClC in the plasma membrane (Fig-
ure 1D). In control experiments, we treated cells with bafilomy-
cin, an H+-ATPase inhibitor, and this elevated pH (Figure 2D).
Given that endosomal Cl2 flux is electrogenically linked to
the H+-ATPase [6], we posited that inhibition of the ATPase
should prevent Ins(3,4,5,6)P4 from having any additional effect
upon luminal pH. This was the result that we obtained (Fig-
ure 2D). Cell-permeant Ins(1,4,5,6)P4 was an important nega-
tive control for specificity that had no effect upon endosomal
pH (Figure 2D). The observation that Ins(3,4,5,6)P4 caused en-
dosomal pH to rise in the BHKClC-3 cells but not in WT BHK
cells (Figure 2D) is valuable confirmation that ClC-3
Figure 2. Ins(3,4,5,6)P4 Regulates Endosomal
Acidification by Inhibiting ClC-3
(A) Lysates of BHK cells (control) or BHKClC-3
cells were separated by 7% SDS-PAGE and
transferred to nitrocellulose, and ClC-3 was de-
tected with a murine monoclonal antibody. The
same antibody was used for detection of ClC-3
in methanol-fixed cells via immunofluorescence
microscopy (see Experimental Procedures).
(B) WT BHK cells or BHKClC-3 cells were each al-
lowed to endocytose FITC-transferrin at 37C.
For calibration purposes, cells were equilibrated
in buffers of known pH containing ionophores,
followed by fluorescence-ratio imaging. An ex-
ample (for BHKClC-3 cells at pH 7.3) is shown in
(B), and for clarity of presentation (but not during
data analysis), the brightness and contrast were
increased by 30% with Microsoft Powerpoint.
One cell is magnified and annotated with yellow
arrows to highlight the regions that were defined
as vesicular early endosomes and selected for
pH analysis [32].
(C) A representative calibration plot is shown.
(D) Endosomal pH in cells that were treated either
for 30 min with 0.5 mM bafilomycin or for 1 hr with
100 mM Bt2-Ins(3,4,5,6)P4/PM, 100 mM Bt2-
Ins(1,4,5,6)P4/PM, or 200 mM butyrate (Bt). Data
are from 3–6 experiments. Asterisks indicate
p < 0.001 versus control.
(E) Cells were treated for 1 hr with 0, 10, 20, or
100 mM Bt2-Ins(3,4,5,6)P4/PM. The data (n = 3–4)
show the relationship between DpH and the
estimated (EST) intracellular concentration of
Ins(3,4,5,6)P4, based upon a delivery efficiency
([Ins(3,4,5,6)P4]IN / [Bt2-Ins(3,4,5,6)P4/PM]OUT) of
16% [13, 34] and assuming 1 mM Ins(3,4,5,6)P4 in
resting cells [13].
In panels that contain error bars, these represent
standard errors of the mean.
contributes to vesicle acidification. En-
dosomal ClC-3 must now be considered
a regulated signaling entity rather than
merely subservient to vesicle acidifica-
tion. The occurrence of this regulatory
process in endosomes has additional
significance; the endosomal compartment is a cell-signaling
nexus from which emerges many of the spatiotemporal proper-
ties of certain biological messengers [35]; our data add an ino-
sitol phosphate to this complex, multifactorial paradigm.
Our results (Figure2D) indicate that theendogenousCl2chan-
nels and/or transporters that are insensitive to Ins(3,4,5,6)P4 in
WT BHK cells are unable to compensate for inhibition of exoge-
nous ClC-3 in the BHKClC-3 cells. This might simply reflect inher-
ent kinetic differences between ClC isoforms, although it is also
possible that overexpression of ClC-3 leads to a decrease in
endosomal expression of endogenous Cl2 transporters.
Are other members of the ClC family regulated by
Ins(3,4,5,6)P4? There is no evidence for this in WT BHK cells, in
which Ins(3,4,5,6)P4 had no effect upon the endosomal pH set
by endogenous Cl2 transporters (Figure 2D). In order to further
study this idea, we utilized Caco-2 cells, for two reasons. First,
they express very little ClC-3 protein [22, 27]. Second, previous
work with these cells [25] has revealed that endosomal pH is
set by endogenous heterodimers of ClC-4 and ClC-5, such
that inhibition of either protein alone is sufficient to promote
endosomal alkalosis. We again used FITC-transferrin to record
Inositol(3,4,5,6)tetrakisphosphate and ClC-3
1603endosomal pH. The value that we obtained (6.176 0.08; n = 15)
was unchanged (6.12 6 0.13; n = 3) by 2 hr treatment with
100 mM Bt2-Ins(3,4,5,6)P4/PM. Therefore, we conclude that
Ins(3,4,5,6)P4 does not significantly regulate endosomal pH
through an interaction with either ClC-4 or ClC-5.
We next studied the influence of Ins(3,4,5,6)P4 upon plasma
membrane Cl2 current in another context; namely, neonatal
hippocampal neurones. This particular endogenous Cl2 cur-
rent has conclusively been attributed to ClC-3, because it is
absent from clc-32/2 mice [31]. The unitary conductance of
this ClC-dependent Cl2 current is relatively low (3 pS), and
two-pore (‘‘double-barreled’’) behavior was observed [31];
both of these characteristics are distinguishing properties of
Figure 3. CaMKII-Activated ClC-3 Current Is Inhibited by Ins(3,4,5,6)P4 in
Cultured Rat P5 Hippocampal Neurons
Whole-cell currents were obtained, as described in Figure 1, from cultured
hippocampal neurons in which autonomous CaMKII (20 mg/ml) was included
in the pipette solution for 25 min plus, where indicated, either 10 mM
Ins(3,4,5,6)P4 or 100 mM Ins(1,3,4,5,6)P5.
(A) Families of currents recorded during hyperpolarizing and depolarizing
voltage pulses.
(B) Relationship between current and voltage.
(C) Average current densities at 110 mV and 2110mV, with cell numbers
indicated below each bar.
In panels that contain error bars, these represent standard errors of the mean.the ClC family [6]. The introduction of CaMKII into hippocam-
pal neurones dramatically activated a whole-cell Cl2 current
that displayed outward rectification (Figure 3), similar to the
CaMKII-activated, ClC-3-mediated Cl2 current in tsA cells
(Figure 1). When we perfused Ins(3,4,5,6)P4 into the neuronal
cells, the CaMKII-activated Cl2 current was almost completely
inhibited (Figure 3). In control experiments, Ins(1,3,4,5,6)P5 did
not affect Cl2 current (Figure 3). This specific regulation of Cl2
fluxes by Ins(3,4,5,6)P4 is likely to have regulatory significance;
an interplay between the degree of activation of ClC-3 and
NMDA receptors may control the synaptic efficacy in generat-
ing action potentials [31]. Long-term changes in synaptic
efficacy are thought to form a cellular basis for information
storage and memory formation. Thus, Ins(3,4,5,6)P4 is a mole-
cule that has the potential to affect neuronal development,
through its ability to regulate ClC-3 activity.
ClC-3 has many other roles, including tumor cell migration
[7], bone remodeling [36], apoptosis [8], and inflammatory re-
sponses [9]. We can now anticipate that Ins(3,4,5,6)P4 might
also regulate these processes. Overall, our study shows that
Ins(3,4,5,6)P4 is an intracellular signal with a far greater biolog-
ical repertoire than has previously been appreciated. The
knowledge that ClC-3 function is regulated by Ins(3,4,5,6)P4
is also a substantial experimental advance, because it offers
new opportunities for determining the mechanism of action
of this inositol phosphate.
Experimental Procedures
Cell Culture
Caco-2 cells were cultured in DMEM:F12 (GIBCO no.11330) with 10% FBS
(Hyclone) and 5% CO2. BHK-21 cells were grown in DMEM/F12, 5% FBS
at 37C in 5%CO2. These cells were stably transfected with human ClC-3
(also known as ‘‘long-ClC-3A’’; GenBank accession no. NP_001820) in
pcDNA3 and pNUT vector with the use of Lipofectamine Plus (Invitrogen).
BHKClC-3 cells were selected with the use of 500 mM methotrexate in the
growth medium. The ClC-3 cDNA was also subcloned in the pcDNA3.1
zeo+ vector (Invitrogen, CA) and was transfected into tsA cells with Super-
Fect reagent (QIAGEN, CA) (see [21] for details). The tsAClC-3 cells were se-
lected with zeocin (Invitrogen) at 400 mg/ml and maintained at 200 mg/ml. P5
hippocampal neuronal cultures were obtained as previously described [31].
Endosomal pH Measurements
The endosomal pH of Caco-2 and BHK cells was determined through fluo-
rescence-ratio imaging of FITC-transferrin [25]. Cells plated on glass bottom
coverslip dishes (MatTek, Ashland, MA) were allowed to reach 90% conflu-
ency and were serum-starved for 2 hr. Endosomes were identified by incu-
bation of cells for 20–180 min at 37C with 200 mg/ml FITC-transferrin (Invi-
trogen) in medium containing 140 mM NaCl, 5 mM KCl, 5 mM glucose, 1 mM
CaCl2, 1 mM MgCl2, 10 mM HEPES, pH 7.4 (endosomal pH was independent
of the time of incubation with FITC-transferrin). Cells were incubated at 37C
with either 0.5 mM bafilomycin (30 min; dissolved in methanol), vehicle, or
cell-permeant Bt2-Ins(3,4,5,6)P4/PM or Bt2-Ins(1,4,5,6)P4/PM (SiChem, Bre-
men, Germany) for 2 hr. The vehicle for the inositol phosphate analogs was
a mixture of anhydrous methyl sulfoxide (Sigma) and pluronic (final concen-
trations 0.36% and 0.02%, respectively).
For removal of surface-bound FITC-transferrin, cells were washed three
times at 37C with phosphate-buffered saline (pH 5.0). Cells were imaged
with a PlanApo 633/1.4 Oil DIC63X objective on an LSM 510 meta-NLO
mounted on an Axiovert 100M microscope and acquired with the Carl Zeiss
LSM 510 software v.3.2 SP2 (Carl Zeiss, Thornwood, NY). Pixel width was
set to 0.07 mm, and a pinhole setting of 1 Airy unit was used. The focal plane
was then adjusted to acquire images from the center of the cells. FITC-
transferrin was visualized by acquiring sequential images with the use of ex-
citation wavelengths of 488 nm and then 458 nm, while the emission signal
was consistently collected with a 505 nm low-pass filter. Each dual-excita-
tion image pair was imported into the MetaFluor Offline software, v.6.3r6
(Molecular Devices, Downingtown, PA), where approximately 10–12 endo-
somes from 3–4 cells were classified as regions of interest (ROI) by manual
definition of a circle (103 6 3 pixels) around a vesicular endosome. The
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tensity taken from the emission signal at 488 nm excitation (pH dependent)
and divided by the emission signal collected when 458 nm excitation
(pH independent) was used. In cases when the intensity of a given ROI
was low, we performed a background subtraction, the value of which was
defined from an equivalently sized ‘‘ROI’’ placed outside the cell. The data
derived by the MetaFluor software were then exported to Microscoft Excel.
The relationship between fluorescence ratio and pH was determined by
equilibration of cells in a series of standards (in which the pH was adjusted
from 5.7 to 7.3) with the use of the following medium: 140 mM KCl, 10 mM
NaCl, 10 mM HEPES, 5 mM glucose, 1 mM CaCl2, 1 mM MgCl2, 20 mM
monensin, and 20 mM nigericin.
Immunofluorescence Microscopy
BHK-21 cells were fixed in MeOH (220C) for 10 min, permeabilized with
0.1% Saponin in PBS (4C, 60 min), and blocked with 5% goat serum, 1%
BSA in PBS. Mouse monoclonal antibody 34.1 [22] was applied at a concen-
tration of 3 mg/ml followed by goat anti-mouse Alexa Fluor 488 IgG conju-
gate (2.5 mg/ml) for detection of ClC-3. Cells were imaged with a Plan-Apo-
chromat 633/NA:1.4 Oil DIC objective on a Zeiss LSM 510 confocal laser-
scanning microscope. Excitation was at 488 nm via an Argon Laser,
a BP505-530 filter was employed for emission. DIC, and fluorescence
images were obtained simultaneously. The pinhole setting was 1 Airy unit.
Electrophysiology
All patch-clamp recordings were made with quartz pipettes and an EPC-9
amplifier (HEKA Elektronik, Lambrecht[Pfalz], Germany). Extra- and intra-
cellular solutions were designed such that Cl2 was the primary charge car-
rier. The bath solution contained: 140 mM HCl, 140 mM methyl D-glucamine,
2 mM CaCl2, 1 mM MgCl2, and 10 mM HEPES pH 7.4. The pipette solution
contained 40 mM HCl, 100 mM L-glutamic acid, 140 mM methyl D-gluc-
amine, 0.2 mM CaCl2, 2 mM MgCl2, 1 mM EGTA, 10 mM HEPES, pH 7.2,
and 2 mM ATP-Mg. Free Ca2+ was calculated to be 40 nM. Ca2+-indepen-
dent, autonomously active, autophosphorylated CaMKII was prepared daily
[21] and was introduced into the cell via the patch pipette. The Cl2 equilib-
rium potential was calculated to be 231 mV . Under these ionic conditions,
nonspecific leak current was identified as a depolarizing shift in reversal po-
tential. Currents were elicited through a series of test pulses from 2110 to
110 mV in 10 mV increments from a holding potential of240 mV. Test pulses
(200 ms) were delivered at 2 s intervals. Current recordings were acquired at
2 kHz and filtered at 1 kHz.
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